WS #10588
Absci stock surges 24% on positive Phase 1 hair loss drug data, a significant catalyst for the biotech.
Absci Positive Phase 1 Data
Absci stock surges 24% on positive Phase 1 hair loss drug data, a significant catalyst for the biotech.
Absci stock surges 24% on positive Phase 1 hair loss drug data, a significant catalyst for the biotech.
Absci stock surges 24% on positive Phase 1 hair loss drug data, a significant catalyst for the biotech.